Replimune Group, Inc. SEC filings REPL
Replimune Group, Inc. has 657 filings in SEC EDGAR's recent list, going back to May 3, 2018. Its latest annual report, Form ARS, was filed on Jul 29, 2026 for the period ended Mar 31, 2026. The latest quarterly report (Form 10-Q) was filed on Oct 28, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (results of operations). The company's fiscal year ends on March 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3ASR | Automatic shelf registration | Aug 14, 2026 | — |
| 424B5 | Prospectus supplement | Aug 10, 2026 | — |
| S-3/A | Filing | Jul 24, 2026 | — |
| S-8 | Employee stock plan registration | Jun 29, 2026 | — |
| S-3/A | Filing | Nov 6, 2025 | — |
| S-3 | Shelf registration | May 23, 2025 | — |
| S-3 | Shelf registration | May 23, 2025 | — |
| S-8 | Employee stock plan registration | May 23, 2025 | — |
| S-8 | Employee stock plan registration | Apr 25, 2025 | — |
| S-8 | Employee stock plan registration | Mar 14, 2025 | — |
| S-8 | Employee stock plan registration | Feb 12, 2025 | — |
| S-8 | Employee stock plan registration | Jan 17, 2025 | — |
| S-8 | Employee stock plan registration | Dec 20, 2024 | — |
| 424B5 | Prospectus supplement | Nov 26, 2024 | — |
| 424B5 | Prospectus supplement | Nov 25, 2024 | — |
| S-8 | Employee stock plan registration | Nov 19, 2024 | — |
| S-8 | Employee stock plan registration | Oct 16, 2024 | — |
| S-3 | Shelf registration | Aug 8, 2024 | — |
| S-8 | Employee stock plan registration | May 16, 2024 | — |
| POS AM | Filing | May 16, 2024 | — |
| S-3ASR | Automatic shelf registration | Aug 3, 2023 | — |
| S-8 | Employee stock plan registration | May 18, 2023 | — |
| 424B5 | Prospectus supplement | Dec 12, 2022 | — |
| 424B5 | Prospectus supplement | Dec 7, 2022 | — |
| S-3 | Shelf registration | Jun 23, 2022 | — |
| S-8 | Employee stock plan registration | May 20, 2021 | — |
| 424B5 | Prospectus supplement | Nov 5, 2020 | — |
| 424B5 | Prospectus supplement | Oct 23, 2020 | — |
| FWP | Free writing prospectus | Oct 21, 2020 | — |
| 424B5 | Prospectus supplement | Oct 20, 2020 | — |
| S-3 | Shelf registration | Aug 11, 2020 | — |
| 424B5 | Prospectus supplement | Jun 10, 2020 | — |
| 424B5 | Prospectus supplement | Jun 8, 2020 | — |
| 424B5 | Prospectus supplement | Nov 18, 2019 | — |
| FWP | Free writing prospectus | Nov 14, 2019 | — |
| 424B5 | Prospectus supplement | Nov 12, 2019 | — |
| S-3 | Shelf registration | Aug 8, 2019 | — |
| S-8 | Employee stock plan registration | Jul 24, 2018 | — |
| 424B4 | Prospectus | Jul 23, 2018 | — |
| S-1/A | Amended registration statement | Jul 17, 2018 | — |
| S-1/A | Amended registration statement | Jul 10, 2018 | — |
| S-1/A | Amended registration statement | Jun 26, 2018 | — |
| S-1 | Registration statement | Jun 22, 2018 | — |
Showing 43 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- REPL (Nasdaq)
- Fiscal year ends
- March 31
- Incorporated in
- DE
- Headquarters
- Woburn, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1737953
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.